Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104945410B details asymmetric catalysis for high-purity intermediates. This method ensures scalable production and significant cost efficiency for global supply chains.
Patent CN110423219A reveals aqueous resolution for high-purity R-tetrahydropapaverine. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106279032B details gold catalysis for five-membered nitrogen heterocycles offering high yield and simplified supply chain for pharmaceutical intermediate manufacturing.
Patent CN112341406B details a novel 3-step synthesis for trans-4-[4-(3-methoxy-4-nitrophenyl)-1-piperazinyl]adamantane-1-ol, offering superior stereocontrol and scalability for oncology drug development.
Discover the clean production method for 2-fluoro-4-nitrobenzonitrile via patent CN103694137A, offering reduced waste and energy-efficient manufacturing for kinase inhibitors.
Advanced recrystallization technology removes critical impurity imA from Mirabegron. Enhances purity to over 99.9 percent for reliable pharmaceutical supply chains.
Patent CN113149851A details a high-yield 4-step synthesis for stable isotope labeled chlorpropaline, offering cost-effective solutions for residue detection.
Novel cyclization method for taxane side chains ensures high yield and purity. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN104327039A reveals enzymatic synthesis for rosuvastatin intermediate offering milder conditions and reduced solvent consumption for supply chain optimization.
Discover high-purity cephalosporin intermediates via patent CN1243755C. Enhanced yield, crystalline stability, and cost-effective manufacturing for global supply chains.
Patent CN107400036A reveals rhodium-catalyzed synthesis enabling high enantioselectivity. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105837493A offers mild condition Nintedanib synthesis. Enhances yield and supply chain stability for pharmaceutical intermediates manufacturing globally.
Novel process for Citalopram using 5-carboxy-2-benzo[c]furanone. Reduces heavy metal use and improves scalability for pharmaceutical manufacturing.
Patent CN104151342B details a scalable synthesis route for pinacol boronic ester offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN101368199A details immobilized enzyme hydrolysis for high-purity D-amino acids. This green process ensures stable supply chain and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106397241A enables solvent-free crystallization and high aniline recovery for cost reduction in API manufacturing and supply chain reliability.
Patent CN113788872B details a high-yield route for steroid intermediates. This method offers significant purity improvements and cost-effective scaling for global supply chains.
Patent CN112390767A details a novel Grignard route for high-purity Eperisone Impurity F. This method ensures superior regioselectivity and supply chain stability for API manufacturers.
Patent CN109776624B details a high-purity synthesis of Tribenoside avoiding chromatography, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Discover the advanced one-step synthesis of (E)-1-chloro-6,6-dimethyl-2-hepten-4-yne. A cost-effective, high-yield route for scalable Terbinafine HCl manufacturing.